REPLICA announces its third Harmonization Meeting
The REPLICA Project is proud to announce the third Harmonization meeting involving researchers and international partners. The two-day session is going to be held on May 26 and May 28 2021
Replica (CoEHAR): is there any correlation between Covid-19 and Harm Reduction?
A new study by CoEHAR, the "Role of Cigarette Smoke on Angiotensin-Converting Enzyme-2 Protein Membrane Expression in Bronchial Epithelial Cells Using an Air-Liquid Interface Model" investigates the molecular mechanisms that regulate the expression of the ACE2 enzyme, involved in Covid-19 infection
SRNT 2021- Giovanni Li Volti: “A potential role of nicotine as a protective factor from Covid-19”
Catania February, 2021 – The Director of CoEHAR Giovanni Li Volti presented at the meeting of the Society for Research on Nicotine & Tobacco (SRNT 2021) the study “The Role of cigarette…
COVID-19 and the human body: nicotine as a “controller” of the molecular expression of ACE-2
Nicotine is a protective shield against the insurgence of severe symptoms of COVID-19. This is what emerged with the new study by CoEHAR
CoEHAR’s research awarded on SRNT 2021 annual meeting
The Society for Research on Nicotine & Tobacco (SRNT) shortlisted the Center of Excellence for the acceleration of Harm Reduction (CoEHAR) for the 2021 edition of its annual meeting, hosted online from 24th to 27th of February
